4//SEC Filing
LEDERMAN SETH 4
Accession 0001839882-25-011952
CIK 0001430306other
Filed
Feb 26, 7:00 PM ET
Accepted
Feb 27, 6:48 PM ET
Size
15.1 KB
Accession
0001839882-25-011952
Insider Transaction Report
Form 4
LEDERMAN SETH
DirectorPresident and CEO
Transactions
- Other
Common Stock, $0.001 par value
2025-02-05$0.15/sh−1$0→ 0 total(indirect: By Spouse) - Other
Common Stock, $0.001 par value
2025-02-05$3.38/sh−5.18$18→ 5 total - Other
Common Stock, $0.001 par value
2025-02-05$3.30/sh−0.22$1→ 1 total(indirect: By IRA) - Award
Stock Option
2025-02-25+123,958→ 123,958 totalExercise: $8.05From: 2026-02-25Exp: 2035-02-25→ Common Stock (123,958 underlying) - Award
Stock Option
2025-02-25+123,958→ 123,958 totalExercise: $10.06From: 2026-02-25Exp: 2035-02-25→ Common Stock (123,958 underlying)
Holdings
- 1(indirect: Lederman & Co.)
Common Stock, $0.001 par value
- 1(indirect: By IRA)
Common Stock, $0.001 par value
- 5
Common Stock, $0.001 par value
Footnotes (4)
- [F1]Reporting person may be deemed to be a control person of this entity.
- [F2]Involuntary sale of fractional share following a reverse stock split of the Issuer's common stock.
- [F3]One-third of the option vests on the first anniversary of issuance and 1/36th each month thereafter for 24 months.
- [F4]The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan.
Documents
Issuer
Tonix Pharmaceuticals Holding Corp.
CIK 0001430306
Entity typeother
Related Parties
1- filerCIK 0001563420
Filing Metadata
- Form type
- 4
- Filed
- Feb 26, 7:00 PM ET
- Accepted
- Feb 27, 6:48 PM ET
- Size
- 15.1 KB